12.07.2015 Views

The Clinical Guide to Supportive and Palliative Care for HIV/AIDS

The Clinical Guide to Supportive and Palliative Care for HIV/AIDS

The Clinical Guide to Supportive and Palliative Care for HIV/AIDS

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

A <strong>Clinical</strong> <strong>Guide</strong> <strong>to</strong> <strong>Supportive</strong> <strong>and</strong> <strong>Palliative</strong> <strong>Care</strong> <strong>for</strong> <strong>HIV</strong>/<strong>AIDS</strong> • Chapter 3: Assessment of Physical Symp<strong>to</strong>msAs a consequence of this complexity, the measurement of fatigue must attempt <strong>to</strong> capture thisspectrum of disturbances. Although unidimensional scales can <strong>and</strong> have been used <strong>to</strong> assessfatigue, clearly a more meaningful assessment will evaluate its temporal dimensions, physical<strong>and</strong> psychological26 picascomponents, <strong>and</strong> associated distress.Unidimensional fatigue scales include single items in symp<strong>to</strong>m checklists <strong>and</strong> the fatigue subscaleof the Profile of Mood States. 53, 54, 55 Another approach involves the assessment of specific symp<strong>to</strong>msassociated with fatigue—<strong>for</strong> example, a visual analogue scale is used <strong>to</strong> assess “drowsiness”<strong>and</strong> other scales are used <strong>to</strong> evaluate the patient’s cognitive status. Several multidimensionalscales exist, including the 41-item Piper Fatigue Self Report Scale (PFS), which addressesthe severity, distress, <strong>and</strong> impact of fatigue 56 <strong>and</strong> the Visual Analogue Scale-Fatigue measure, an18-item, multidimensional patient-rated instrument. 57 While these scales are more applicablein the research setting than in the general clinical setting, the issues involved in the assessmen<strong>to</strong>f fatigue highlight the need <strong>for</strong> accurate his<strong>to</strong>rytaking so the dimensions of the symp<strong>to</strong>m that isdistressing the patient can be clearly defined.Instruments <strong>for</strong> Assessing Symp<strong>to</strong>ms That May Otherwise Be UnnoticedInstruments <strong>to</strong> detect the presence of symp<strong>to</strong>ms that may otherwise go unnoticed include thoseinstruments that routinely ask patients about the presence or absence of a symp<strong>to</strong>m (or multiplesymp<strong>to</strong>ms) <strong>and</strong> those that assess <strong>for</strong> the presence of impaired cognition. Some symp<strong>to</strong>msmay not be reported but may nonetheless be important. Consequently, clinicians may elect <strong>to</strong>include routine measuring of such symp<strong>to</strong>ms in clinical care. For this purpose, clinicians mayuse instruments <strong>for</strong> the assessment of a single symp<strong>to</strong>m (e.g., pain) or multiple symp<strong>to</strong>ms.Cognitive impairment <strong>and</strong> its associated symp<strong>to</strong>ms, problems common in hospitalized patients<strong>and</strong> those with far advanced illness, are amenable <strong>to</strong> such routine moni<strong>to</strong>ring. <strong>The</strong>re are manyinstruments available <strong>for</strong> cognitive assessment. 58 In the clinical setting, some clinicians includebrief cognitive screens in routine assessment <strong>to</strong> improve their ability <strong>to</strong> detect such problems.Screening tests <strong>for</strong> cognitive impairment include the Mini Mental Status Exam 59 <strong>and</strong> the BlessedOrientation-Memory-Concentration Test, 60 Figures 3-5 <strong>and</strong> 3-6, respectively. Although these <strong>to</strong>olshave been shown <strong>to</strong> be sensitive indica<strong>to</strong>rs of impairment, 61, 62, 63 clinicians must be cautionedthat the instruments are not specific <strong>for</strong> the diagnosis of delirium or dementia, both of whichmay occur in advanced <strong>HIV</strong>-related illness. Further assessment would be needed <strong>to</strong> make thesediagnoses. (See Chapter 10: Psychiatric Problems.)Instruments <strong>for</strong> Assessing Multiple Symp<strong>to</strong>msInstruments may be needed <strong>to</strong> assess <strong>and</strong> moni<strong>to</strong>r multiple symp<strong>to</strong>ms. To date, only a smallamount of research has focused on the role in routine clinical use of instruments that assessmultiple symp<strong>to</strong>ms. Even less in<strong>for</strong>mation is available that applies directly <strong>to</strong> patients with <strong>HIV</strong>infection.In clinical settings, the main problem with instruments that assess multiple symp<strong>to</strong>ms has beentheir length (which may limit their clinical utility <strong>for</strong> routine use). Nonetheless, some instrumentsare available that could be considered <strong>for</strong> use in moni<strong>to</strong>ring multiple symp<strong>to</strong>ms. <strong>The</strong> Edmon<strong>to</strong>nSymp<strong>to</strong>m Assessment Scale (ESAS) is a nine-item, patient-rated symp<strong>to</strong>m visual analogue scale64U.S. Department of Health <strong>and</strong> Human Services • Health Resources <strong>and</strong> Services Administration • <strong>HIV</strong>/<strong>AIDS</strong> Bureau

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!